respiratory disease
Illumina Acquires IDbyDNA
The firms have had an alliance for the past two years and market a respiratory pathogen panel.
US DoD, Henry M. Jackson Foundation Award LightDeck Dx $2M for Multiplexed Respiratory Illness Test
The firm will develop a rapid test for its LightDeck analyzer to detect C-reactive proteins, inducible-proteins 10 (IP-10 or CXCL-10), and other inflammatory markers.
Owlstone Medical Raises $58M in Series D Financing Round
The company said it has a pipeline of research-use-only panels and diagnostic tests that are in development for lung cancer, liver disease, and respiratory disease.
Owlstone Medical Entering Digestive Health Dx Space With Launch of Breath-Based Testing Service
Premium
The company is preparing to provide a clinical testing service that integrates hydrogen and methane biomarkers for digestive health conditions.
DiaSorin to Acquire Luminex for $1.8B
DiaSorin said that the transaction is expected to be immediately accretive to its earnings per share and result in cost synergies of about $55 million within three years.